Piver M S, Barlow J J, Xynos F P
Am J Obstet Gynecol. 1978 Jun 1;131(3):311-3. doi: 10.1016/0002-9378(78)90607-5.
One hundred consecutive evaluable patients with advanced carcinoma of the cervix or vagina were treated with doxorubicin (Adriamycin) alone or in combination. The use of Adriamycin in conjunction with cyclophosphamide and 5-fluorouracil resulted in the highest response rate with all responders continuing to respond.
连续100例可评估的晚期宫颈癌或阴道癌患者接受了单独或联合使用阿霉素( Adriamycin )的治疗。阿霉素与环磷酰胺和5-氟尿嘧啶联合使用时,缓解率最高,且所有缓解者持续缓解。